BI-6901 is a selective CCR10 antagonist. In a DNFB-induced contact hypersensitivity mouse model, it demonstrates dose-dependent anti-inflammatory activity. This small molecule inhibitor is a valuable research tool for studying CCR10-mediated immune responses in both in vitro and in vivo experimental settings.